Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Nanoparticle albumin-bound (nab)-paclitaxel has better efficacy and practically eliminates the risk of hypersensitivity reactions associated with solvent-based paclitaxel. We studied weekly nab-paclitaxel and gemcitabine combination in an open-label one-stage, phase II trial in patients with previou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Roy, V., LaPlant, B. R., Gross, G. G., Bane, C. L., Palmieri, F. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2009
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2733073/
https://ncbi.nlm.nih.gov/pubmed/19087987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn661
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak